University of Copenhagen, Herlev Hospital, Herlev, Denmark.
Bladder pain syndrome (BPS), commonly referred to as "interstitial cystitis", is no longer considered a rare disorder. It may affect up to 2.7% of the adult female population (Ueda et al. in Int J Urol 10:1-70, 2003) with up to 20% of cases occurring in men.
The last two decades have seen a worldwide effort to try to standardize its nomenclature, definition, diagnosis, and treatment algorithm. The literature has been reviewed.
In this article, we will detail current terminology, diagnostic approaches and treatment. Standard therapies will be discussed, and a section that concentrates on the management of the subset of patients with a Hunner's lesion will be highlighted.
BPS is today viewed through a new paradigm. It is no longer considered primarily a bladder disease, but rather one of a number of chronic pain syndromes that is distinguished by being manifest through bladder-related symptoms. A distinct subgroup of patients with Hunner's lesion has specific characteristics, and successful treatment of this subgroup is available.
Written by:
Nordling J, Fall M, Hanno P. Are you the author?
Reference: World J Urol. 2011 Nov 5. Epub ahead of print.
doi: 10.1007/s00345-011-0785-x
PubMed Abstract
PMID: 22057291
UroToday.com IC/PBS/BPS/HBS Section
